Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study
- PMID: 32948149
- PMCID: PMC7501713
- DOI: 10.1186/s12879-020-05416-6
Tuberculosis clinical presentation and treatment outcomes in pregnancy: a prospective cohort study
Abstract
Background: There is limited research to guide TB treatment specifically in pregnant women and few studies have described the presentation of TB in pregnant women. We aimed to understand TB presentation and treatment outcomes in pregnant women in a low HIV burden setting. We describe a cohort of women of childbearing age treated for TB disease in Lima, Peru, and compare clinical presentation and treatment outcomes among pregnant and non-pregnant women between 2009 and 2012, including 36 pregnant women.
Methods: This is a prospective cohort study. Subjects were recruited from across 106 public health centers in Lima, Peru. Baseline demographic, medical history, and drug-susceptibility test results were collected. We used descriptive statistics to describe demographic and clinical characteristics of the women using Pearson chi-squared, Fisher's exact tests, or Kruskal-Wallis.
Results: Among 4500 individuals with pulmonary TB disease, 1334 women were included in analysis with 36 (2.69%) pregnant women. Pregnant women had similar demographics, past medical histories, and clinical presentation to non-pregnant women, except being more likely to be married (p = 0.01) and have cardiac disease (p = 0.04) and less likely to have weight loss (p = 0.05). Twenty (71.4%) pregnant women had pan-susceptible TB compared with 616 (63.1%) non-pregnant women; four (14.3%) pregnant women had mono-resistant TB compared with 154 (15.8%) non-pregnant women; and four (14.3%) pregnant women had multi-drug-resistant TB compared with 140 (14.3%) of non-pregnant women (p = 0.53). Twenty-eight (96.6%) pregnant women had a successful outcome (cure, completed treatment, treatment ended early by clinical team) while one (3.4%) had an unsuccessful outcome (treatment failed) and 1074 (97.3%) non-pregnant women had a successful outcome while 30 (2.7%) had an unsuccessful outcome (p = 0.56).
Conclusion: In this cohort with low HIV co-infection, we found high TB treatment success rates in both pregnant and non-pregnant women, irrespective of drug-susceptibility profiles. If treated appropriately, pregnant women with TB disease can have successful outcomes.
Keywords: Epidemiology; Perinatal TB; Pregnancy.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.J Infect Public Health. 2016 Jul-Aug;9(4):465-70. doi: 10.1016/j.jiph.2015.11.016. Epub 2015 Dec 20. J Infect Public Health. 2016. PMID: 26711476
-
Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.BMC Pregnancy Childbirth. 2021 Jun 28;21(1):453. doi: 10.1186/s12884-021-03956-6. BMC Pregnancy Childbirth. 2021. PMID: 34182944 Free PMC article.
-
Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.PLoS One. 2020 Sep 24;15(9):e0239018. doi: 10.1371/journal.pone.0239018. eCollection 2020. PLoS One. 2020. PMID: 32970722 Free PMC article.
-
Tuberculosis in pregnancy: a review.J Pregnancy. 2012;2012:379271. doi: 10.1155/2012/379271. Epub 2011 Nov 1. J Pregnancy. 2012. PMID: 22132339 Free PMC article. Review.
-
State-of-the-Art Review of HIV-TB Coinfection in Special Populations.Clin Pharmacol Ther. 2018 Dec;104(6):1098-1109. doi: 10.1002/cpt.1221. Epub 2018 Oct 26. Clin Pharmacol Ther. 2018. PMID: 30137652 Review.
Cited by
-
Best practices for the care of pregnant people living with TB.Int J Tuberc Lung Dis. 2023 May 1;27(5):357-366. doi: 10.5588/ijtld.23.0031. Int J Tuberc Lung Dis. 2023. PMID: 37143222 Free PMC article. Review.
-
The clinical presentation and detection of tuberculosis during pregnancy and in the postpartum period in low- and middle-income countries: A systematic review and meta-analysis.PLOS Glob Public Health. 2023 Aug 23;3(8):e0002222. doi: 10.1371/journal.pgph.0002222. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37611006 Free PMC article.
-
Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis.JAMA Netw Open. 2022 Jun 1;5(6):e2216527. doi: 10.1001/jamanetworkopen.2022.16527. JAMA Netw Open. 2022. PMID: 35687333 Free PMC article.
-
Evidence for Implementation: Management of TB in HIV and Pregnancy.Curr HIV/AIDS Rep. 2022 Dec;19(6):455-470. doi: 10.1007/s11904-022-00641-x. Epub 2022 Oct 29. Curr HIV/AIDS Rep. 2022. PMID: 36308580 Free PMC article. Review.
-
The mark of success: The role of vaccine-induced skin scar formation for BCG and smallpox vaccine-associated clinical benefits.Semin Immunopathol. 2024 Aug 26;46(5):13. doi: 10.1007/s00281-024-01022-9. Semin Immunopathol. 2024. PMID: 39186134 Free PMC article. Review.
References
-
- World Health Organization . TB and Gender. Geneva: WHO; 2018. p. 2.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous